Analyst Ratings For NASDAQ:CSBR – Champions Oncology (NASDAQ:CSBR)
Today, Dawson James initiated coverage on NASDAQ:CSBR – Champions Oncology (NASDAQ:CSBR) with a Buy with a price target of $10.00.
Some recent analyst ratings include
- 5/15/2018-Dawson James initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:CSBR – Champions Oncology (NASDAQ:CSBR)
NASDAQ:CSBR – Champions Oncology (NASDAQ:CSBR) has insider ownership of 44.30% and institutional ownership of 39.13%.
- On 3/27/2018 Ronnie Morris, CEO, bought 4,535 with an average share price of $3.59 per share and the total transaction amounting to $16,280.65.
- On 3/22/2018 Ronnie Morris, CEO, bought 260 with an average share price of $3.49 per share and the total transaction amounting to $907.40.
- On 10/21/2016 Ronnie Morris, President, bought 30,000 with an average share price of $1.66 per share and the total transaction amounting to $49,800.00.
- On 10/19/2016 Ronnie Morris, President, bought 10,000 with an average share price of $1.70 per share and the total transaction amounting to $17,000.00.
- On 10/18/2016 Joel Ackerman, CEO, bought 2,000 with an average share price of $1.70 per share and the total transaction amounting to $3,400.00.
- On 10/14/2016 Joel Ackerman, CEO, bought 7,300 with an average share price of $1.67 per share and the total transaction amounting to $12,191.00.
- On 10/14/2016 Ronnie Morris, President, bought 10,305 with an average share price of $1.66 per share and the total transaction amounting to $17,106.30.
Recent Trading Activity for NASDAQ:CSBR – Champions Oncology (NASDAQ:CSBR)
Shares of NASDAQ:CSBR – Champions Oncology closed the previous trading session at 4.28 up +0.03 0.71% with 1964 shares trading hands.